
无锡晶海 — Investor Relations & Filings
Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年第一次临时股东大会决议公告 | 2025-01-15 | Chinese | |
| 东方证券股份有限公司关于无锡晶海氨基酸股份有限公司变更部分募投项目实施主体的专项核查意见 | 2024-12-29 | Chinese | |
| 关于公司吸收合并全资子公司暨变更部分募投项目实施主体的公告 | 2024-12-29 | Chinese | |
| 第四届董事会第五次会议决议 | 2024-12-29 | Chinese | |
| 第四届董事会第二次独立董事专门会议决议 | 2024-12-29 | Chinese | |
| 第四届监事会第四次会议决议 | 2024-12-29 | Chinese |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
1 filing
| |||||
| 39971321 | 2025年第一次临时股东大会决议公告 | 2025-01-15 | Chinese | ||
|
2024
14 filings
| |||||
| 39971314 | 东方证券股份有限公司关于无锡晶海氨基酸股份有限公司变更部分募投项目实施主体的专项核查意见 | 2024-12-29 | Chinese | ||
| 39971303 | 关于公司吸收合并全资子公司暨变更部分募投项目实施主体的公告 | 2024-12-29 | Chinese | ||
| 39971296 | 第四届董事会第五次会议决议 | 2024-12-29 | Chinese | ||
| 39971291 | 第四届董事会第二次独立董事专门会议决议 | 2024-12-29 | Chinese | ||
| 39971282 | 第四届监事会第四次会议决议 | 2024-12-29 | Chinese | ||
| 39971274 | 关于召开2025年第一次临时股东大会会议通知 | 2024-12-29 | Chinese | ||
| 39971267 | 股票解除限售公告 | 2024-12-19 | Chinese | ||
| 39971259 | 第四届董事会第一次独立董事专门会议决议 | 2024-12-04 | Chinese | ||
| 39971249 | 舆情管理制度 | 2024-12-04 | Chinese | ||
| 39971234 | 第四届监事会第三次会议决议 | 2024-12-04 | Chinese | ||
| 39971225 | 关于通过募集资金保证金账户方式开具银行承兑汇票支付募投项目款项的公告 | 2024-12-04 | Chinese | ||
| 39971213 | 第四届董事会第四次会议决议 | 2024-12-04 | Chinese | ||
| 39971206 | 东方证券股份有限公司关于无锡晶海氨基酸股份有限公司通过募集资金保证金账户方式开具银行承兑汇票支付募投项目款项的专项核查意见 | 2024-12-04 | Chinese | ||
| 39971196 | 2024年三季度报告 | 2024-10-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
无锡晶海 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58862/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58862 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58862 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58862 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58862}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 无锡晶海 (id: 58862)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.